Autologous Ovarian Tumor Cell Lysate-Pulsed Dendritic Cell Vaccine
Term · Oncology and biomedicine · MLC-T-ONC-011733
A cell-based cancer vaccine composed of autologous, irradiated dendritic cells (DCs) pulsed with ovarian tumor cell lysate containing tumor associated antigens (TAAs) with potential immunostimulatory and antineoplastic activities. Upon administration, autologous ovarian tumor cell lysate-pulsed dendritic cell vaccine may stimulate an anti-tumoral cytotoxic T-lymphocyte (CTL) response against ovarian tumor cells expressing the patients ovarian tumor cell-specific TAAs, which may result in ovarian tumor cell lysis.
| Identifier | MLC-T-ONC-011733 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011733",
"term": "Autologous Ovarian Tumor Cell Lysate-Pulsed Dendritic Cell Vaccine",
"field": "Oncology and biomedicine",
"definition": "A cell-based cancer vaccine composed of autologous, irradiated dendritic cells (DCs) pulsed with ovarian tumor cell lysate containing tumor associated antigens (TAAs) with potential immunostimulatory and antineoplastic activities. Upon administration, autologous ovarian tumor cell lysate-pulsed dendritic cell vaccine may stimulate an anti-tumoral cytotoxic T-lymphocyte (CTL) response against ovarian tumor cells expressing the patients ovarian tumor cell-specific TAAs, which may result in ovarian tumor cell lysis.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-ovarian-tumor-cell-lysate-pulsed-dendritic-cell-vaccine/"
}
Record 3,069 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.